AGX51
|
A647164-25mg
|
≥99% |
330834-54-3 |
25mg
|
¥ 7920.9
|
期货,请咨询 |
阿拉丁 |
AGX51
|
A647164-10mg
|
≥99% |
330834-54-3 |
10mg
|
¥ 4400.9
|
期货,请咨询 |
阿拉丁 |
AZ1495
|
A647159-5mg
|
≥98% |
2196204-23-4 |
5mg
|
¥ 2980.9
|
期货,请咨询 |
阿拉丁 |
AZ1495
|
A647159-50mg
|
≥98% |
2196204-23-4 |
50mg
|
¥ 11000.9
|
期货,请咨询 |
阿拉丁 |
AZ1495
|
A647159-25mg
|
≥98% |
2196204-23-4 |
25mg
|
¥ 7800.9
|
期货,请咨询 |
阿拉丁 |
AZ1495
|
A647159-1mg
|
≥98% |
2196204-23-4 |
1mg
|
¥ 1485.9
|
期货,请咨询 |
阿拉丁 |
AZ1495
|
A647159-10mg
|
≥98% |
2196204-23-4 |
10mg
|
¥ 5500.9
|
期货,请咨询 |
阿拉丁 |
AM103
|
A647147-5mg
|
≥99% |
1147872-22-7 |
5mg
|
¥ 5600.9
|
期货,请咨询 |
阿拉丁 |
AM103
|
A647147-10mg
|
≥99% |
1147872-22-7 |
10mg
|
¥ 9000.9
|
期货,请咨询 |
阿拉丁 |
Aristololactam IIIa
|
A647107-1mg
|
|
97399-89-8 |
1mg
|
¥ 6500.9
|
期货,请咨询 |
阿拉丁 |
Ampreloxetine hydrochloride
|
A647084-5mg
|
|
1227056-87-2 |
5mg
|
¥ 2400.9
|
期货,请咨询 |
阿拉丁 |
Ampreloxetine hydrochloride
|
A647084-50mg
|
|
1227056-87-2 |
50mg
|
¥ 12500.9
|
期货,请咨询 |
阿拉丁 |
Ampreloxetine hydrochloride
|
A647084-25mg
|
|
1227056-87-2 |
25mg
|
¥ 7800.9
|
期货,请咨询 |
阿拉丁 |
Ampreloxetine hydrochloride
|
A647084-10mg
|
|
1227056-87-2 |
10mg
|
¥ 3900.9
|
期货,请咨询 |
阿拉丁 |
ARD-61
|
A647077-1mg
|
≥99% |
2316837-08-6 |
1mg
|
¥ 9000.9
|
期货,请咨询 |
阿拉丁 |
AKT-IN-3
|
A647070-5mg
|
≥99% |
2374740-21-1 |
5mg
|
¥ 8500.9
|
期货,请咨询 |
阿拉丁 |
AKT-IN-3
|
A647070-10mg
|
≥99% |
2374740-21-1 |
10mg
|
¥ 14000.9
|
期货,请咨询 |
阿拉丁 |
Anagyrine
|
A647058-5mg
|
≥97% |
486-89-5 |
5mg
|
¥ 4100.9
|
期货,请咨询 |
阿拉丁 |
Anagyrine
|
A647058-1mg
|
≥97% |
486-89-5 |
1mg
|
¥ 1400.9
|
期货,请咨询 |
阿拉丁 |
Alicapistat
|
A647057-5mg
|
≥98% |
1254698-46-8 |
5mg
|
¥ 7500.9
|
期货,请咨询 |
阿拉丁 |
Alicapistat
|
A647057-10mg
|
≥98% |
1254698-46-8 |
10mg
|
¥ 12000.9
|
期货,请咨询 |
阿拉丁 |
Anticancer agent 73
|
A647056-5mg
|
≥99% |
124811-87-6 |
5mg
|
¥ 600.9
|
期货,请咨询 |
阿拉丁 |
Anticancer agent 73
|
A647056-50mg
|
≥99% |
124811-87-6 |
50mg
|
¥ 3000.9
|
期货,请咨询 |
阿拉丁 |
Anticancer agent 73
|
A647056-25mg
|
≥99% |
124811-87-6 |
25mg
|
¥ 2000.9
|
期货,请咨询 |
阿拉丁 |